This inventor holds 1 USPTO granted patent and 1 published patent application and 4 EPO patents. Top assignee: Global Life Sciences USA LLC. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Patrick Guertin
Introduction
Patrick Guertin is an accomplished inventor based in Mendon, MA (US). He has made significant contributions to the field of bioreactor systems, particularly in the area of continuous perfusion bioreactor technology. His innovative approach has the potential to enhance cell culture and pharmaceutical manufacturing processes.
Latest Patents
Guertin holds a patent for a Continuous Perfusion Bioreactor System. This patent encompasses systems and methods for containing and manipulating liquids, including vessels and unit operations or components of cell culture, cell containment, bioreactor, and pharmaceutical manufacturing systems. The invention includes an apparatus in the form of a bioreactor designed for harvesting cells. It features a disposable, collapsible bag for containing liquid, which is in fluid communication with a liquid-solids separation device. This innovative design allows for the efficient re-harvesting of cells after separation from the liquid.
Career Highlights
Throughout his career, Patrick Guertin has worked with notable companies such as Global Life Sciences USA LLC and Global Life Sciences Solutions USA LLC. His experience in these organizations has contributed to his expertise in biotechnological innovations and systems.
Collaborations
Guertin has collaborated with professionals like Parrish M Galliher and Geoffrey L Hodge. These partnerships have likely enriched his work and expanded the impact of his inventions.
Conclusion
Patrick Guertin's contributions to the field of bioreactor systems exemplify the importance of innovation in biotechnology. His patent for the Continuous Perfusion Bioreactor System showcases his commitment to advancing cell culture and pharmaceutical manufacturing technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile